2-[2-hydroxyethyl-[4-[(4-methoxyphenyl)methylamino]-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-6-yl]amino]ethanol
C20H28N6O3 — CID 177372534
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[2-hydroxyethyl-[4-[(4-methoxyphenyl)methylamino]-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-6-yl]amino]ethanol
2-[2-hydroxyethyl-[4-[(4-methoxyphenyl)methylamino]-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-6-yl]amino]ethanol (PubChem CID 177372534) has the molecular formula C20H28N6O3 and a molecular weight of 400.48 g/mol. Its IUPAC name is 2-[2-hydroxyethyl-[4-[(4-methoxyphenyl)methylamino]-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-6-yl]amino]ethanol.
Molecular Properties
| Compound Name | 2-[2-hydroxyethyl-[4-[(4-methoxyphenyl)methylamino]-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-6-yl]amino]ethanol |
|---|---|
| PubChem CID | 177372534 |
| Molecular Formula | C20H28N6O3 |
| Molecular Weight | 400.48 g/mol |
| Exact Mass | 400.22 |
| IUPAC Name | 2-[2-hydroxyethyl-[4-[(4-methoxyphenyl)methylamino]-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-6-yl]amino]ethanol |
| SMILES | COc1ccc(CNc2nc(N(CCO)CCO)nc3c2cnn3C(C)C)cc1 |
| InChI | InChI=1S/C20H28N6O3/c1-14(2)26-19-17(13-22-26)18(21-12-15-4-6-16(29-3)7-5-15)23-20(24-19)25(8-10-27)9-11-28/h4-7,13-14,27-28H,8-12H2,1-3H3,(H,21,23,24) |
| InChIKey | JTZIKJJODWLHHP-UHFFFAOYSA-N |
| XLogP | 1.82 |
| TPSA | 108.56 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 400.48 |
| LogP ≤ 5 | 1.82 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177372534 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.